FCM
Farallon Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,000
| Closed | -$299K | – | 163 |
|
|
2024
Q1 | $299K | Hold |
2,000
| – | – | ﹤0.01% | 128 |
|
|
2023
Q4 | $383K | Hold |
2,000
| – | – | ﹤0.01% | 111 |
|
|
2023
Q3 | $354K | Hold |
2,000
| – | – | ﹤0.01% | 120 |
|
|
2023
Q2 | $380K | Sell |
2,000
-4,719
| -70% | -$896K | ﹤0.01% | 130 |
|
|
2023
Q1 | $1.35M | Sell |
6,719
-123,337
| -95% | -$24.7M | 0.01% | 138 |
|
|
2022
Q4 | $30.9M | Sell |
130,056
-298,400
| -70% | -$70.9M | 0.18% | 72 |
|
|
2022
Q3 | $85.8M | Sell |
428,456
-359,454
| -46% | -$71.9M | 0.47% | 53 |
|
|
2022
Q2 | $115M | Sell |
787,910
-235,963
| -23% | -$34.4M | 0.62% | 48 |
|
|
2022
Q1 | $167M | Sell |
1,023,873
-166,155
| -14% | -$27.1M | 0.81% | 34 |
|
|
2021
Q4 | $202M | Buy |
1,190,028
+375,727
| +46% | +$63.7M | 1.01% | 30 |
|
|
2021
Q3 | $154M | Sell |
814,301
-135,699
| -14% | -$25.6M | 0.72% | 39 |
|
|
2021
Q2 | $161M | Buy |
950,000
+250,000
| +36% | +$42.4M | 0.66% | 39 |
|
|
2021
Q1 | $98.8M | Buy |
700,000
+350,000
| +100% | +$49.4M | 0.49% | 46 |
|
|
2020
Q4 | $45.5M | Sell |
350,000
-850,000
| -71% | -$110M | 0.27% | 64 |
|
|
2020
Q3 | $175M | Buy |
1,200,000
+150,000
| +14% | +$21.8M | 1.21% | 32 |
|
|
2020
Q2 | $156M | Sell |
1,050,000
-450,000
| -30% | -$66.6M | 1.24% | 33 |
|
|
2020
Q1 | $163M | Buy |
1,500,000
+50,000
| +3% | +$5.44M | 1.4% | 25 |
|
|
2019
Q4 | $167M | Sell |
1,450,000
-50,000
| -3% | -$5.76M | 1.13% | 29 |
|
|
2019
Q3 | $121M | Buy |
1,500,000
+400,000
| +36% | +$32.2M | 0.91% | 28 |
|
|
2019
Q2 | $79.8M | Buy |
1,100,000
+600,000
| +120% | +$43.5M | 0.52% | 42 |
|
|
2019
Q1 | $46.7M | Sell |
500,000
-50,000
| -9% | -$4.67M | 0.35% | 53 |
|
|
2018
Q4 | $40.1M | Buy |
550,000
+273,449
| +99% | +$19.9M | 0.29% | 47 |
|
|
2018
Q3 | $24.2M | Sell |
276,551
-138,449
| -33% | -$12.1M | 0.14% | 59 |
|
|
2018
Q2 | $40.9M | Buy |
415,000
+45,000
| +12% | +$4.43M | 0.25% | 54 |
|
|
2018
Q1 | $44.1M | Buy |
+370,000
| New | +$44.1M | 0.31% | 51 |
|
|
2017
Q3 | – | Sell |
-200,000
| Closed | -$16M | – | 84 |
|
|
2017
Q2 | $16M | Buy |
+200,000
| New | +$16M | 0.17% | 58 |
|